Maxwell Biomedical Information

Rhythm360: The First-Ever CRT for the Atrium (CRT-A) — Restoring Sinus Rhythm and Atrial Function in AF-HF Patients Without Destruction MaxWell Biomedical is creating a new category in cardiac rhythm management (CRM) with Rhythm360, the first implantable system designed to restore sinus rhythm and atrial function, non-destructively—directly addressing the root cause of electromechanical dysfunction in patients with atrial fibrillation (AF) and heart failure (HF). RECRUITMENT NOTICE: MaxWell Biomedical does not recruit through Text, Teams, Telegram, WhatsApp, etc. Do not communicate with anyone claiming to be from MaxWell from outside the “maxwellbiomed.com” email domain.